Exploring the antimicrobial efficacy of Manuka honey against multidrug-resistant and extensively drug-resistant Salmonella Typhi causing septicemia in Pakistan

  • Published on 26/06/2025
  • Rate this article:
  •  Reading time: 1 min.

Iqra Bashir a , Muhammad Hidayat Rasool a , Muhammad Shafique a , Kokab Jabeen b & Muhammad Usman Qamar * a

a Institute of Microbiology, Faculty of Life Sciences, Government College University Faisalabad, Faisalabad, 38000, Pakistan
b Department of Pathology, Ameer ud Din Medical College/Lahore General Hospital, Lahore, Pakistan

* CONTACT: mailto:musmanqamar@gcuf.edu.pk

Abstract

Aim To determine the efficacy of manuka honey against multidrug-resistant (MDR) and extensively drug-resistant (XDR) clinical strains of SalmonellaTyphi.

Materials & methods: Clinical isolates were processed using the Bactec blood culture system, identification and antibiogram by Vitek 2 and antibiotic resistance genes through polymerase chain reaction (PCR). Microbroth dilution assays evaluated the antibacterial activity of manuka honey.
Results MDR and XDR-S. Typhi was susceptible to azithromycin. These strains carried the H58, gyrA, gyrB, blaCTX-M-15 , and blaTEM-1 genes. At 100% honey, the zone of inhibition for MDR (15–23 mm) and XDR (15–24 mm) strains. 18/50 MDR and 14/50 XDR strains inhibited at 3.125 v/v% killed at 6.25 v/v% concentration respectively.
Conclusion Manuka honey could be an alternative option for treating S. Typhi infections.

Keywords: antimicrobial-resistant genes, manuka honey, MDR, Salmonella Typhi, septicemia, XDR.


Peer-Reviewed Journals A-Z

Search  | Advanced search

My bibliography

Access your favorite articles, annotate and compile them by folders or export them in ENDNOTE format!

CISTM19